World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   8608 records for 1694 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
Not RecruitingYesCTRI/2018/01/011249
A large study in kids from birth to 18 years of age that have a clot in their lungs, limbs, to test a new drug (edoxaban) compared to current drugs used for treatment and to prevent further clots in your body
10-01-2018Yes
Not RecruitingYesCTRI/2018/01/011183
A Study to review the Effectiveness and Safety of QAW039 in Patients With Severe Asthma who are Inadequately Controlled With Standard of Care Treatment.
08-01-2018Yes
Not RecruitingYesDRKS00013556
The use of remifentanil for attenuation of maternal pressor response to endotracheal intubation and surgical incision during the induction-delivery period of caesarean section performed under general anesthesia: comparison of two dosing regimens
11/12/2017 
Not RecruitingYesCTRI/2017/12/010783
Study of Selinexor in pateints with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
06-12-2017Yes
AuthorisedYesEUCTR2017-001596-23-SI
Fixed-Dose Combination of Perindopril/Amlodipine (Amlessa®) and Fixed-Dose Combination of Perindopril/Indapamide /Amlodipine (Co-Amlessa®) - Contribution to Management in newly diagnosed and uncontrolled hypertensive patients (PRECIOUS study)
05/12/2017Yes
RecruitingYesNCT03371017
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2016-005119-42-HU A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients with Early Relapsing Recurrent Triple-Negative Breast Cancer 23/11/2017Yes
21/11/2017 
RecruitingYesNCT03377699
Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes
16/11/2017 
RecruitingYesNCT03345836
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
15/11/2017 
RecruitingYesNCT03345823
A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433
15/11/2017 
RecruitingYesNCT03345849
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
15/11/2017 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history